[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$951m](/topic/$951m) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "1/ 💰 New Benchmark for China Biotech M&A Sino Biopharm just bought LaNova for $951M. But 💵 $450M of that is LaNovas own cash. 🧾 Real EV = $501M just XXX cash. A global-validated biotech at book value. Let that sink in" [@BowTiedBiotech](/creator/x/BowTiedBiotech) on [X](/post/tweet/1946260380818321616) 2025-07-18 17:26:49 UTC 19.5K followers, XXX engagements "Chinese biotech behind Merck & Co.'s PD-1/VEGF play sold for $951M via @fwpharma" [@TinaWitte](/creator/x/TinaWitte) on [X](/post/tweet/1945474448410165671) 2025-07-16 13:23:48 UTC XXX followers, XX engagements "A look into the future Sino Biopharm buys Merck's PD-1xVEGF bispecific partner LaNova for up to $951M Lots of 👀👀👀 on this bispecific and the collaboration" [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1945286039603454405) 2025-07-16 00:55:08 UTC 12.5K followers, 2374 engagements "🧵 Sino Biopharm Acquires Merck's PD-1xVEGF Bispecific Partner LaNova for up to $951M #SinoBiopharmLanova" [@TalkBioNews](/creator/x/TalkBioNews) on [X](/post/tweet/1945276989750821115) 2025-07-16 00:19:10 UTC XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"1/ 💰 New Benchmark for China Biotech M&A Sino Biopharm just bought LaNova for $951M. But 💵 $450M of that is LaNovas own cash. 🧾 Real EV = $501M just XXX cash. A global-validated biotech at book value. Let that sink in"
@BowTiedBiotech on X 2025-07-18 17:26:49 UTC 19.5K followers, XXX engagements
"Chinese biotech behind Merck & Co.'s PD-1/VEGF play sold for $951M via @fwpharma"
@TinaWitte on X 2025-07-16 13:23:48 UTC XXX followers, XX engagements
"A look into the future Sino Biopharm buys Merck's PD-1xVEGF bispecific partner LaNova for up to $951M Lots of 👀👀👀 on this bispecific and the collaboration"
@JamesEKrause on X 2025-07-16 00:55:08 UTC 12.5K followers, 2374 engagements
"🧵 Sino Biopharm Acquires Merck's PD-1xVEGF Bispecific Partner LaNova for up to $951M #SinoBiopharmLanova"
@TalkBioNews on X 2025-07-16 00:19:10 UTC XX followers, XX engagements
/topic/$951m/posts